Bio View (BIOV) Financial Statements

0 Followers

Bio View Financial Overview

Bio View's market cap is currently ₪22.93M. The company's EPS TTM is -0.024; its P/E ratio is -1.48; Bio View is scheduled to report earnings on ―, and the estimated EPS forecast is ―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	₪ 19.93M	₪ 25.66M	₪ 34.77M	₪ 29.14M	₪ 30.51M
Gross Profit	₪ 8.75M	₪ 15.56M	₪ 21.38M	₪ 16.67M	₪ 17.59M
Operating Income	₪ -7.80M	₪ -2.88M	₪ 766.00K	₪ 1.15M	₪ 2.95M
EBITDA	₪ -5.96M	₪ -943.00K	₪ 2.93M	₪ 2.61M	₪ 4.45M
Net Income	₪ -15.33M	₪ -3.15M	₪ 383.00K	₪ 587.00K	₪ 2.18M
Balance Sheet
Cash & Short-Term Investments	₪ 7.22M	₪ 10.94M	₪ 17.11M	₪ 19.44M	₪ 19.22M
Total Assets	₪ 19.89M	₪ 33.62M	₪ 41.95M	₪ 41.93M	₪ 40.02M
Total Debt	₪ 2.79M	₪ 1.98M	₪ 3.51M	₪ 4.06M	₪ 4.61M
Net Debt	₪ -2.13M	₪ -6.24M	₪ -12.18M	₪ -15.38M	₪ -14.62M
Total Liabilities	₪ 10.47M	₪ 10.68M	₪ 14.65M	₪ 13.65M	₪ 12.86M
Stockholders' Equity	₪ 9.41M	₪ 22.95M	₪ 27.30M	₪ 28.28M	₪ 27.16M
Cash Flow
Free Cash Flow	₪ -3.11M	₪ -3.14M	₪ -121.00K	₪ 511.00K	₪ 2.59M
Operating Cash Flow	₪ -3.06M	₪ -3.11M	₪ 153.00K	₪ 968.00K	₪ 3.25M
Investing Cash Flow	₪ 255.00K	₪ -1.54M	₪ -1.67M	₪ -567.00K	₪ -740.00K
Financing Cash Flow	₪ 425.00K	₪ -2.95M	₪ -2.68M	₪ -1.61M	₪ -268.00K

Currency in ILS

Bio View Earnings and Revenue History

Income Statement >

Bio View Debt to Assets

Balance Sheet >

Bio View Cash Flow

Cash Flow >

Bio View Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >